A detailed history of Cerity Partners LLC transactions in Vericel Corp stock. As of the latest transaction made, Cerity Partners LLC holds 67,588 shares of VCEL stock, worth $3.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,588
Previous 30,277 123.23%
Holding current value
$3.93 Million
Previous $1.39 Million 105.54%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$42.25 - $53.56 $1.58 Million - $2 Million
37,311 Added 123.23%
67,588 $2.86 Million
Q2 2024

Aug 13, 2024

SELL
$41.71 - $52.9 $167,549 - $212,499
-4,017 Reduced 11.71%
30,277 $1.39 Million
Q1 2024

May 14, 2024

BUY
$32.52 - $52.33 $1.12 Million - $1.79 Million
34,294 New
34,294 $1.78 Million
Q1 2023

May 11, 2023

BUY
$23.85 - $31.34 $61,056 - $80,230
2,560 New
2,560 $75,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.74B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.